Monika Hegi

Monika Hegi

Université de Lausanne

H-index: 83

Europe-Switzerland

About Monika Hegi

Monika Hegi, With an exceptional h-index of 83 and a recent h-index of 49 (since 2020), a distinguished researcher at Université de Lausanne, specializes in the field of brain tumors, epigenetics, predicitive factors, translational research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms

Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline

Epigenetic silencing of HTATIP2 in glioblastoma contributes to treatment resistance by enhancing nuclear translocation of the DNA repair protein MPG

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation

Towards more Diversity in Neuro-oncology Leadership—the DivINe Initiative

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection

Monika Hegi Information

University

Position

Full Professor Hospital Switzerland

Citations(all)

48088

Citations(since 2020)

21259

Cited By

34703

hIndex(all)

83

hIndex(since 2020)

49

i10Index(all)

158

i10Index(since 2020)

110

Email

University Profile Page

Université de Lausanne

Google Scholar

View Google Scholar Profile

Monika Hegi Skills & Research Interests

brain tumors

epigenetics

predicitive factors

translational research

Top articles of Monika Hegi

Title

Journal

Author(s)

Publication Date

Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms

Cancer Cell

Leire Bejarano

Annamaria Kauzlaric

Eleni Lamprou

Joao Lourenco

Nadine Fournier

...

2024/1/8

Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors

Cell Reports Medicine

Ángel F Álvarez-Prado

Roeltje R Maas

Klara Soukup

Florian Klemm

Mara Kornete

...

2023/1/17

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline

Felix Sahm

Sebastian Brandner

Luca Bertero

David Capper

Pim J French

...

2023/10/1

Epigenetic silencing of HTATIP2 in glioblastoma contributes to treatment resistance by enhancing nuclear translocation of the DNA repair protein MPG

Molecular Oncology

Thi Tham Nguyen

Premnath Rajakannu

Minh Diêu Thanh Pham

Leo Weman

Alexander Jucht

...

2023/9

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

European Journal of Cancer

Caroline Hertler

Jörg Felsberg

Dorothee Gramatzki

Emilie Le Rhun

Jennifer Clarke

...

2023/8/1

Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation

Nature Cancer

Vladimir Wischnewski

Roeltje R Maas

Paola Guerrero Aruffo

Klara Soukup

Giovanni Galletti

...

2023/6

Towards more Diversity in Neuro-oncology Leadership—the DivINe Initiative

Neuro-oncology

Sylvia C Kurz

Anja Stammberger

Steffen K Rosahl

Lauren E Abrey

Nathalie L Albert

...

2023/12/1

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection

David Capper

Guido Reifenberger

Pim J French

Leonille Schweizer

Michael Weller

...

2023/5/1

The local microenvironment drives activation of neutrophils in human brain tumors

Cell

Roeltje R Maas

Klara Soukup

Nadine Fournier

Matteo Massara

Sabine Galland

...

2023/10/12

Senescence is the main trait induced by temozolomide in glioblastoma cells

Cancers

Lea Beltzig

Christian Schwarzenbach

Petra Leukel

Katrin BM Frauenknecht

Clemens Sommer

...

2022/4/29

DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients

Acta neuropathologica communications

Pierre Bady

Christine Marosi

Michael Weller

Bjørn H Grønberg

Henrik Schultz

...

2022/3/24

BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression

Cell Death & Disease

Alessandro Tancredi

Olga Gusyatiner

Pierre Bady

Michelle C Buri

Rémy Lomazzi

...

2022/12/13

Evolution patterns of glioblastoma from single-cell whole-genome sequencings

Brain Tumor Research and Treatment

Hyeok Choi

Woo Jong Cho

Olga Gusyatiner

Pierre Bady

Manuel Bueno

...

2022/3/15

Epigenetic silencing of HTATIP2 in glioblastoma enhances nuclear translocation of the DNA-repair protein MPG affecting treatment resistance

Monika Hegi

Thi Tham Nguyen

Premnath Rajakannu

Minh Diêu Thanh Pham

Leo Weman

...

2022/11/15

Weakly supervised learning with automated labels from radiology reports for glioma change detection

arXiv preprint arXiv:2210.09698

Tommaso Di Noto

Meritxell Bach Cuadra

Chirine Atat

Eduardo Gamito Teiga

Monika Hegi

...

2022/10/18

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller

Martin van den Bent

Matthias Preusser

Emilie Le Rhun

Jörg C Tonn

...

2022/5

Hyperpolarized 13C-glucose magnetic resonance highlights reduced aerobic glycolysis in vivo in infiltrative glioblastoma

Scientific Reports

Mor Mishkovsky

Olga Gusyatiner

Bernard Lanz

Cristina Cudalbu

Irene Vassallo

...

2021/3/11

Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis

Nature cancer

Florian Klemm

Aylin Möckl

Anna Salamero-Boix

Tijna Alekseeva

Alexander Schäffer

...

2021/10

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Michael Weller

Martin van den Bent

Matthias Preusser

Emilie Le Rhun

Jörg C Tonn

...

2021/3

BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma

Neuro-oncology

Olga Gusyatiner

Pierre Bady

Minh DT Pham

Yvonne Lei

Jungyeon Park

...

2021/10/1

See List of Professors in Monika Hegi University(Université de Lausanne)